Cencora, Inc. (BIT:1COR)

Market Cap	48.02B
Revenue (ttm)	269.63B
Net Income (ttm)	1.62B
Shares Out	n/a
EPS (ttm)	8.24
PE Ratio	29.72
Forward PE	17.10
Dividend	2.10 (0.86%)
Ex-Dividend Date	May 15, 2025

Volume	n/a
Average Volume	2
Open	245.10
Previous Close	245.10
Day's Range	245.10 - 245.10
52-Week Range	232.25 - 266.65
Beta	n/a
RSI	28.23
Earnings Date	Aug 6, 2025

About Ligand Pharmaceuticals

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company’s U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply ...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1871
• Employees: 46,000
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1COR

Financial Performance

In 2024, Cencora's revenue was $293.96 billion, an increase of 12.12% compared to the previous year's $262.17 billion. Earnings were $1.51 billion, a decrease of -13.53%.